GROUPE BERKEM |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.39 EUR | 0.00% |
|
+55.19% | -21.90% |
| Apr. 30 | Groupe Berkem Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 06 | Givaudan: agreement signed with Berkem | CF |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2023 | 52.4M 56.43M | Sales 2024 * | 58.7M 63.22M | Capitalization | 42.24M 45.49M |
|---|---|---|---|---|---|
| Net income 2023 | - 0 | Net income 2024 * | 1M 1.08M | EV / Sales 2023 | 1.03 x |
| Net Debt 2023 * | 16.43M 17.7M | Net Debt 2024 * | 27.05M 29.13M | EV / Sales 2024 * | 1.18 x |
| P/E ratio 2023 |
153
x | P/E ratio 2024 * |
23.9
x | Employees | 234 |
| Yield 2023 * |
2.51% | Yield 2024 * |
1.26% | Free-Float | 31.92% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 week | +55.19% | ||
| Current month | +37.36% | ||
| 1 month | +33.89% | ||
| 3 months | +0.84% | ||
| 6 months | +42.69% | ||
| Current year | -21.90% |
1 week
1.58
2.66
1 month
1.352.66
Current year
1.353.70
1 year
1.186.10
3 years
1.1810.50
5 years
1.1810.50
10 years
1.1810.50
| Managers | Title | Age | Since |
|---|---|---|---|
Olivier Fahy
CEO | Chief Executive Officer | 58 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Olivier Fahy
CEO | Chief Executive Officer | 58 | - |
Fahy Stanislas
BRD | Director/Board Member | - | 21-03-07 |
Lambert Thierry
BRD | Director/Board Member | - | 21-03-07 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 2.39 | 0.00% | 22,491 |
| 24-05-09 | 2.39 | +9.63% | 77,570 |
| 24-05-08 | 2.18 | +14.74% | 41,257 |
| 24-05-07 | 1.9 | +13.10% | 41,188 |
| 24-05-06 | 1.68 | +9.09% | 21,267 |
Real-time Euronext Paris, May 10, 2024 at 11:23 am EDT
More quotes
Berkem Group is a chemical group organized around 4 business units:
- production of active ingredients: from the extraction of plant materials. In addition, the group offers freeze-drying services for the food, cosmetics, nutraceutical and pharmaceutical industries, etc.;
- formulation of solutions for the preservation and protection of materials: in particular wood materials;
- distribution of solutions for the treatment, machining and protection of wood materials;
- manufacture of alkyd resins: for the paint, construction, wood treatment and ink industries.
At the end of 2023, the company has 3 production sites located in France.
France accounts for 71.6% of net sales.
Sector
Pharmaceuticals
Calendar
2024-06-24
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.39
EUR
Average target price
5.233
EUR
Spread / Average Target
+118.97%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -21.90% | 45.49M | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| -2.71% | 159B |
- Stock Market
- Equities
- ALKEM Stock
